View of Resistance-associated substitution and LEDIPASVIR/SOFOSBUVIR therapy in Mongolian chronic hepatitis C patients

Return to Issue Details Resistance-associated substitution and LEDIPASVIR/SOFOSBUVIR therapy in Mongolian chronic hepatitis C patients Download Download PDF